Emergent Biosolutions Financials

Values in thousands	2024-09-30	2024-06-30	2024-03-31	2023-12-31
Revenue	$269,500	$254,700	$300,400	$276,600
Gross Profit	269,500	-54,500	139,400	74,800
EBITDA	64,500	-216,800	65,200	-1,800
EBIT	38,100	-246,200	36,400	-32,300
Net Income	114,800	-283,100	9,000	-49,500
Net Change In Cash	269,500	254,700	300,400	276,600
Free Cash Flow	147,900	42,900	-73,400	20,700
Cash	149,900	71,000	79,000	111,700
Basic Shares	55,600	52,600	52,200	51,900

Values in thousands	2023-12-31	2022-12-31	2021-12-31	2020-12-31
Revenue	$1,049,300	$1,120,900	$1,792,700	$1,555,400
Gross Profit	343,900	427,200	1,035,200	1,031,400
EBITDA	-505,299	-34,400	458,200	549,000
EBIT	-630,399	-166,000	331,900	434,600
Net Income	-760,500	-223,800	219,500	305,800
Net Change In Cash	1,049,300	1,120,900	1,792,700	1,555,400
Cost of Revenue		65,800	-44,900	454,500
Free Cash Flow	-257,900	-149,900	96,100	395,000
Cash	111,700	642,600	576,100	621,300
Basic Shares	51,200	50,100	54,100	53,800